Disclosure Of Cash Flow Statement [Text Block]

Hyloris Pharmaceuticals SA - Filing #5880972

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2023-12-31
As at
2022-12-31
Disclosure of cash flow statement [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
2
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
23,594,000 EUR
30,406,000 EUR
33,457,000 EUR
Disclosure of additional information about understanding financial position and liquidity of entity [text block]
15

Talk to a Data Expert

Have a question? We'll get back to you promptly.